Pulmonary mucormycosis developed during acute myelogenous leukemia and successfully treated by surgical resection before blood stem cell transplantation
Authors:
Open Access
- 1 December 2019
- journal article
- Published by AME Publishing Company in AME Case Reports
- Vol. 3, 48
Abstract
Pulmonary mucormycosis is relatively rare and occurs in immunosuppressed patients, for example, individuals with hematologic malignancies such as leukemia. As pulmonary mucormycosis increases rapidly and is often fatal, appropriate treatment including surgical resection is necessary. We report a patient with pulmonary mucormycosis and acute myelogenous leukemia for which antifungal drugs were invalid. After rapid surgical resection, the patient was administered a peripheral blood stem cell transplantation. In conclusion, we emphasize that patients with pulmonary mucormycosis undergoing leukemia treatment should be considered for rapid surgical treatment if the infected lesion is limited, as overcoming this acute infection increases their chance to undergo hematopoietic stem cell transplantation and potential for long-term survival.Keywords
This publication has 7 references indexed in Scilit:
- Pulmonary mucormycosis: clinical features and outcomesInfection, 2017
- Proven invasive pulmonary mucormycosis successfully treated with amphotericin B and surgery in patient with acute myeloblastic leukemia: a case reportJournal of Medical Case Reports, 2013
- Epidemiology and Clinical Manifestations of MucormycosisClinical Infectious Diseases, 2012
- Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported CasesClinical Infectious Diseases, 2005
- Pulmonary MucormycosisArchives of internal medicine (1960), 1999
- Pulmonary ZygomycosisJournal of Computer Assisted Tomography, 1995
- Pulmonary mucormycosis: Results of medical and surgical therapyThe Annals of Thoracic Surgery, 1994